RxSight Inc.
RXST | NASDAQ
$5.14
-$0.06 (-1.15%)
At close: Sep 21, 2026, 4:00 PM ET
$5.10
-$0.04 (-0.76%)
Pre-market:
Sep 22, 2026, 8:45 AM ET
Market Data
Market Cap $212.78M
Enterprise Value $14.56M
Beta 1.16
Average Volume 1.03M
Shares Outstanding (Diluted) 41.49M
Shares Change YoY 1.83%
Institutional Ownership 92.47%
Exchange NASDAQ
ISIN US78349D1072
Price Performance
Price Change 1M -17.6%
Price Change 3M -1.5%
Price Change 6M -22.0%
Price Change YTD -50.5%
Price Change 1Y -46.0%
Price Change 3Y -81.1%
Price Change 5Y -60.7%
1M CAGR (ann.) -17.9%
1Y CAGR (ann.) -45.8%
5Y CAGR (ann.) -17.8%
All-Time CAGR -19.8%
Valuation
PE Ratio -4.55
Forward PE N/A
PEG Ratio 0.14
Forward PEG -0.19
PS Ratio 1.67
Forward PS 1.40
PB Ratio 0.81
P/FCF Ratio -5.48
P/Adj. FCF Ratio -2.72
P/OCF Ratio -9.35
EV/Sales 0.11
EV/EBIT -0.31
EV/EBITDA -0.34
EV/FCF -0.38
Earnings Yield -22.0%
FCF Yield -18.2%
Adj. FCF Yield -36.7%
Financial Health
Net Cash $208.8M
Total Debt $10.58M
Cash & Short-Term Investments $208.8M
Total Assets $352.7M
Current Ratio 4.07
Quick Ratio 3.61
Debt / Equity Ratio 0.04
Debt / EBITDA -0.24
Debt / FCF -0.27
OCF / Debt -3.18
Interest Coverage -3,674.20
Altman Z-Score -0.54
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 77.5%
Operating Profit Margin -43.2%
EBITDA Margin -33.9%
Net Profit Margin -36.8%
FCF Margin -30.4%
Adj. FCF Margin -61.2%
SBC / Revenue 24.6%
SBC Impact (per share) -101.2%
Returns
Return on Assets -13.3%
Return on Equity -17.4%
Return on Invested Capital -20.1%
Return on Capital Employed -20.2%
Return on Tangible Assets -13.3%
Historical Growth (CAGR)
Revenue CAGR 3Y 23.9%
Revenue CAGR 5Y 48.8%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -5.6%
EPS CAGR 5Y 26.7%
EPS CAGR 10Y N/A
FCF CAGR 3Y -2.8%
FCF CAGR 5Y 16.4%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 12
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y 5.4%
Earnings Date Nov 3, 2026
EPS Estimate (next Q) -$0.29
EPS Growth Est (next Q) 20.8%
Revenue Est (next Q) $27.19M
Revenue Growth Est (next Q) -10.3%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $7.50
Price Target Upside 45.9%
Cash Flow
Operating Cash Flow $-33.62M
Free Cash Flow $-38.82M
Adj. Free Cash Flow $-78.1M
FCF Per Share -$0.65
OCF Per Share -$0.55
OCF/S Ratio -17.8%
Income Statement
Revenue $127.58M
Gross Profit $98.87M
Operating Income $-55.11M
EBITDA $-43.29M
Net Income $-46.95M
EPS (Diluted) -$1.13
Revenue / Employee $276.75K
Profit / Employee $-101.84K
Employees 461
Add to Watchlist
Select watchlists to add or remove RXST